Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Tebben

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|October 19, 2012
Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesisCullen L Cavallaro, Stephanie Briceno, Jing Chen, et al.
Journal of Medicinal Chemistry|February 1, 2008
Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical CandidateRobert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery of 4-Azaindole Inhibitors of TGFβRI as Immuno-oncology AgentsYong Zhang, Yufen Zhao, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry|February 10, 2018
Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI)Lalgudi S Harikrishnan, Jayakumar Warrier, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|October 19, 2012
Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesisCullen L Cavallaro, Stephanie Briceno, Jing Chen, et al.
Journal of Medicinal Chemistry|February 1, 2008
Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical CandidateRobert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery of 4-Azaindole Inhibitors of TGFβRI as Immuno-oncology AgentsYong Zhang, Yufen Zhao, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry|February 10, 2018
Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI)Lalgudi S Harikrishnan, Jayakumar Warrier, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
Pageof 5